Meeting the challenge of COPD care delivery in the USA: a multiprovider perspective

MLK Han, CH Martinez, DH Au, J Bourbeau… - The Lancet …, 2016 - thelancet.com
The burden of chronic obstructive pulmonary disease (COPD) in the USA continues to grow.
Although progress has been made in the the development of diagnostics, therapeutics, and …

[HTML][HTML] Cyclophosphamide-methotrexate 'metronomic'chemotherapy for the palliative treatment of metastatic breast cancer. A comparative pharmacoeconomic …

G Bocci, M Tuccori, U Emmenegger, V Liguori… - Annals of oncology, 2005 - Elsevier
Background:: Metronomic chemotherapy—the chronic administration of chemotherapy at
relatively low, minimally toxic doses on a frequent schedule of administration at close …

[PDF][PDF] Pharmacoeconomics: principles, methods and economic evaluation of drug therapies

S Kumar, A Baldi - Pharm Tech Med, 2013 - researchgate.net
Pharmacoeconomics identifies, measures, and compares the costs and consequences of
drug therapy to healthcare systems and society. Due to the high pricing of drug, it is very …

Фармакоэкономика как инструмент клинической фармакологии для оптимизации фармакотерапии (обзор)

ОВ Решетько, КА Луцевич - Ведомости Научного центра …, 2015 - cyberleninka.ru
Фармакоэкономика является важной составляющей в оценке медицинских технологий
и экспертизы лекарственных средств для пациентов. Поскольку она является …

Cost‐effectiveness analysis of epidural morphine/ropivacaine treatment in patients with cancer pain

LB Vieira, CM de Barros, PU Price… - Pain …, 2024 - Wiley Online Library
Background Cancer pain is one of the main causes of human suffering, which can generate
disabilities and compromise quality of life, giving rise to several psychosocial and economic …

Pharmacoeconomy: an indispensable tool for the rationalization of health costs

CA Areda, RC Bonizio, O Freitas - Brazilian Journal of Pharmaceutical …, 2011 - SciELO Brasil
Due to the considerable increase in public expenditure with health issues, mainly regarding
drugs, several countries, including Australia and England, have already implemented, or are …

Sağlık ekonomisi perspektifinden farmakoekonomi

A Acar, S Yeğenoğlu - Hacettepe University Journal of the Faculty of …, 2006 - dergipark.org.tr
Ülkelerin gittikçe artan sağlık harcamaları karşısında kaynakların sınırlı olması, sağlık
ekonomisinin ve bir alt dalı olarak farmakoekonominin ortaya çıkmasına neden olmuştur …

Pharmacoeconomic evaluations of antifungal therapies

CR Hennen - Curr Med Res Opin, 2009 - Taylor & Francis
Invasive fungal infections are a growing source of morbidity and mortality in the United
States and are associated with excess hospital stay and costs. Although clinicians now have …

[PDF][PDF] Improving Australians' access to prescription medicines: Development of pharmacy practice models

T Bessell, J Marriott, L Emmerton, L Nissen - Final Report, 2005 - researchgate.net
In an environment of increasing demands and healthcare costs, the focus of pharmacy must
be on the provision of services that improve the quality use of medicines. Health system …

The pharmacoeconomics of acne treatment: where are we heading?

MJ Inglese, AB Fleischer Jr, SR Feldman… - Journal of …, 2008 - Taylor & Francis
Introduction: The increasing recognition of the finite nature of health care resources has
prompted the evaluation of the economic impact and value of medical interventions through …